Detail akcie Astellas Pharma online

Business Summary: Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2026, Astellas Pharma Inc revenues increased 12% to Y2.139T. Net income applicable to common stockholders increased from Y50.75B to Y291.54B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Research and Development Expense decrease of 4% to Y314.83B (expense).